Compounds > 23-seleno-25-homotaurocholic acid
Page last updated: 2024-09-03

23-seleno-25-homotaurocholic acid and Bone Loss, Perimenopausal

23-seleno-25-homotaurocholic acid has been researched along with Bone Loss, Perimenopausal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dizdarevic, S; Hanly, R; Peters, AM; Ryan, N; Snelling, H; Walker-Bone, K1

Trials

1 trial(s) available for 23-seleno-25-homotaurocholic acid and Bone Loss, Perimenopausal

ArticleYear
Association between bile acid turnover and osteoporosis in postmenopausal women.
    Nuclear medicine communications, 2013, Volume: 34, Issue:6

    Topics: Aged; Aged, 80 and over; Bile Acids and Salts; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Radionuclide Imaging; Taurocholic Acid; Whole Body Imaging

2013